**Keybanc Initiates Overweight Rating for FMC on September 11, 2026**
Keybanc Capital Markets has initiated coverage of FMC Corporation (NYSE:FMC) with an “Overweight” recommendation, reversing a prior downgrade to “Sector Weight” in October 2025. FMC specializes in agricultural chemicals and plant health solutions.
As of September 10, 2026, FMC’s stock closed at $12.08, a decline of 6.93% from $12.98 on September 3, but a 15.49% increase from $10.46 a month earlier. Analyst consensus estimates a mean target of $18.78, suggesting a potential upside of 55.49%. The total recommendations for FMC as of September 1, 2026, include 2 Strong Buy, 5 Buy, 12 Hold, 2 Sell, with no Strong Sell ratings.
In its latest earnings report on July 29, 2026, FMC disclosed an EPS of 0.26, surpassing estimates of 0.2256, but reported revenues of $867 million, down 17% from the same quarter in 2025.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
